Trade Summary

5 days ago, Ferrari Mauro, serving as Dir at Arrowhead Pharmaceuticals, Inc. (ARWR), sold 7,530 shares at $70.00 per share, for a total transaction value of $527,100.00. Following this transaction, Ferrari Mauro now holds 69,053 shares of ARWR.

This sale represents a 10.00% decrease in Ferrari Mauro's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, December 26, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 30, 2025, 4 days after the trade was made.

Arrowhead Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.